PROSTATE A031902
Study #A031902A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First Line Metastatic Castration Resistant Prostate Cancer (CASPAR)
Back To Clinical Trials NCI Database Entry
A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First Line Metastatic Castration Resistant Prostate Cancer (CASPAR)
Back To Clinical Trials NCI Database Entry